L&C Bio announced in a regulatory filing on the 12th that it has finalized the final issue price of new shares from its paid-in capital increase at 39,100 won per share.

The shares to be issued through this capital increase are 3.7 million registered common shares. The par value per share is 500 won, and the total amount to be raised, calculated based on the confirmed issue price, is 144.67 billion won.

According to the filing, the first issue price was calculated at 39,100 won and the second at 42,400 won. In accordance with relevant regulations, the company determined the final issue price based on the lower of the two prices, with the price confirmation date being the 8th.

As for the price calculation method, the first issue price was calculated by applying a 25% discount to the volume-weighted average stock price based on the date three trading days before the new share allocation reference date. The second issue price was also calculated by applying a 25% discount to the volume-weighted average stock price based on the date three trading days before the existing shareholders' subscription date.

The confirmed issue price applies the lower of the first and second issue prices, with a floor of 60% of the reference stock price under relevant laws and regulations.

The company stated that the confirmed issue price applied to the existing shareholders' subscription will also be applied equally to the general public offering issue price.